Clinical Trials Directory

Trials / Completed

CompletedNCT05055570

Angiotensin II Pathway and Postoperative Hypoxemia

The Mechanism Research of Angiotensin II Pathway and Postoperative Hypoxemia

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Beijing Anzhen Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Acute type A aortic dissection is often accompanied by postoperative hypoxemia, the cause of which is not fully understood. Angiotensin II is an important component of the renin-angiotensin system (RAS), which has been suggested to be involved in the development of aortic dissection and pulmonary inflammation.The purpose of this study was to investigate the role and mechanism of angiotensin II pathway in postoperative hypoxemia after acute type A aortic dissection, and to provide reference for clinical application

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2021-08-12
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2021-09-24
Last updated
2024-01-26
Results posted
2024-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05055570. Inclusion in this directory is not an endorsement.